This blog highlights PolicyLab researcher Aletha Akers, MD, MPH, FACOG and her many responsibilities: launching CHOP's new adolescent gynecological consult service; seeing patients in the clinic; and leading two studies.

This blog discusses recent research findings from Dr. David Rubin and his team that found antipsychotics raises the risk of developing Type II diabetes and their recommendations for going forward.

This article highlights the congressional briefing, Reducing Overreliance on Psychotropics for Children and Youth in Foster Care, in which PolicyLab Co-Director Kathleen Noonan discussed an overview of the foster care population. ...

PolicyLab's Kathleen Noonan is quoted discussing guidelines to reduce psychotropic medication use nationwide for children and foster youth.

PolicyLab's Amanda Kreider is interviewed about recent PolicyLab research that studied 1.3 American kids and found that certain antipsychotic medications raise their risk of Type 2 diabetes.

This article discusses recent research findings from Dr. David Rubin and his team that found antipsychotics raises the risk of developing Type II diabetes and their recommendations for going forward.

This article discusses recent findings from Dr. David Rubin and his research team that found children who take second-generation antipsychotics may face an increased risk for Type II diabetes.

This article discusses recent findings from Dr. David Rubin and his research team that found children who take second-generation antipsychotics may face an increased risk for Type II diabetes.

This article discusses recent research findings from Dr. David Rubin and his team that found antipsychotics raises the risk of developing Type II diabetes by 50%; the article discusses recommendations for going forward.

This article discusses recent findings from Dr. David Rubin and his research team that found children who take second-generation antipsychotics may face an increased risk for Type II diabetes.